|
Market Closed -
NYSE
01:30:02 29/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 960.56 USD | -0.67% |
|
-6.75% | +17.10% |
| 21/10 | Cencora to buy American Oncology Network in $2.4 billion deal | RE |
| 21/10 | McKesson Maintains Quarterly Dividend at $0.94 a Share, Payable Jan. 4, 2027 to Shareholders of Record as of Dec. 1 | MT |
Company Valuation: McKesson Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 45,858 | 48,757 | 70,547 | 84,343 | 1,05,996 | 1,12,745 | - | - |
| Change | - | 6.32% | 44.69% | 19.56% | 25.67% | 6.37% | - | - |
| Enterprise Value (EV) 1 | 48,205 | 49,673 | 71,593 | 84,306 | 1,08,547 | 1,16,343 | 1,15,933 | 1,14,649 |
| Change | - | 3.05% | 44.13% | 17.76% | 28.75% | 7.18% | -0.35% | -1.11% |
| P/E | 42.3x | 14.2x | 24x | 26.2x | 22.5x | 24.6x | 19.6x | 17.1x |
| PBR | -19.5x | -27.3x | -36.5x | -41.3x | -47.8x | -41.1x | -76.2x | -318x |
| PEG | - | 0x | -2.3x | 1.8x | 0.5x | 14.58x | 0.8x | 1.2x |
| Capitalization / Revenue | 0.17x | 0.18x | 0.23x | 0.23x | 0.26x | 0.26x | 0.24x | 0.23x |
| EV / Revenue | 0.18x | 0.18x | 0.23x | 0.23x | 0.27x | 0.27x | 0.25x | 0.23x |
| EV / EBITDA | 9.14x | 9.27x | 13.5x | 14x | 15.7x | 15.5x | 14.2x | 12.8x |
| EV / EBIT | 9.94x | 9.96x | 14.6x | 15x | 16.8x | 16.6x | 15.1x | 13.8x |
| EV / FCF | 12.4x | 10.8x | 19.7x | 16.1x | 20.1x | 24.7x | 19.1x | 17.6x |
| FCF Yield | 8.09% | 9.26% | 5.07% | 6.2% | 4.98% | 4.04% | 5.22% | 5.69% |
| Dividend per Share 2 | 1.83 | 2.09 | 2.4 | 2.75 | 3.17 | 3.577 | 3.64 | 4.318 |
| Rate of return | 0.6% | 0.59% | 0.45% | 0.41% | 0.37% | 0.37% | 0.38% | 0.45% |
| EPS 2 | 7.23 | 25.03 | 22.39 | 25.72 | 38.38 | 39.03 | 49.08 | 56.2 |
| Distribution rate | 25.3% | 8.35% | 10.7% | 10.7% | 8.26% | 9.16% | 7.42% | 7.68% |
| Net sales 1 | 2,63,966 | 2,76,711 | 3,08,951 | 3,59,051 | 4,03,430 | 4,31,854 | 4,61,421 | 4,94,421 |
| EBITDA 1 | 5,276 | 5,357 | 5,287 | 6,028 | 6,918 | 7,496 | 8,186 | 8,943 |
| EBIT 1 | 4,849 | 4,985 | 4,901 | 5,618 | 6,465 | 6,989 | 7,690 | 8,317 |
| Net income 1 | 1,114 | 3,560 | 3,002 | 3,295 | 4,762 | 4,868 | 5,704 | 6,263 |
| Net Debt 1 | 2,347 | 916 | 1,046 | -37 | 2,551 | 3,598 | 3,188 | 1,904 |
| Reference price 2 | 306.13 | 356.05 | 536.85 | 672.99 | 865.36 | 960.56 | 960.56 | 960.56 |
| Nbr of stocks (in thousands) | 1,49,798 | 1,36,939 | 1,31,408 | 1,25,326 | 1,22,487 | 1,16,590 | - | - |
| Announcement Date | 05/05/22 | 08/05/23 | 07/05/24 | 08/05/25 | 07/05/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 24.78x | 0.27x | 15.52x | 0.37% | 11TCr | |
| 37.66x | 13.18x | 27.98x | 0.53% | 1,14300Cr | |
| 39.33x | 6.61x | 18.6x | 1.99% | 65TCr | |
| 37.45x | 8.4x | 17.37x | 2.4% | 51TCr | |
| 21.46x | 5.22x | 12.98x | 2.51% | 38TCr | |
| 103.38x | 5.8x | 24.86x | 2.4% | 35TCr | |
| 21.99x | 5.69x | 13.69x | 2.94% | 29TCr | |
| 22.31x | 4.51x | 12.87x | 1.96% | 26TCr | |
| 28.42x | 7.28x | 13.03x | 2.25% | 24TCr | |
| -45.78x | 7.1x | 27.53x | 2.07% | 20TCr | |
| Average | 29.10x | 6.40x | 18.44x | 1.94% | 41.4TCr | |
| Weighted average by Cap. | 34.99x | 8.13x | 20.35x | 1.76% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MCK Stock
- Valuation McKesson Corporation
Select your edition
All financial news and data tailored to specific country editions
